Related Experiment Video
Updated: May 5, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Fecal microbiota transplantation alleviates chronic cerebral hypoperfusion-induced axonal hypomyelination by
Shao-Hua Su1, Ming Chen2, Da-Ding Lu1
1Department of Neurosurgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Abstract:
Fecal microbiota transplantation (FMT), aimed at rebuilding gut microbiota, has been proposed as a potential therapeutic approach to central nervous system (CNS) diseases. However, the therapeutic effects of FMT against demyelination-related white matter injury (WMI) have not yet been clarified under chronic cerebral hypoperfusion (CCH) condition. We therefore explored the potential roles and mechanisms of FMT on CCH-induced WMI, focusing on myelin integrity, axonal survival, and oligodendrogenesis. FMT restored mitochondrial electron transport chain (ETC) complex I-V activities and promoted the changes of pyruvate metabolism from lactate-generated to acetyl-CoA-generated mode, strengthening mitochondrial ATP production. Furthermore, FMT mitigated CCH-induced demyelination and axonal degeneration, effects mediated in part by oligodendrogenesis-dependent remyelination. Moreover, FMT altered CCH-induced gut microbiota composition by increasing the proportions of some bacterial groups including Verrucomicrobiae, Akkermansiaceae, Verrucomicrobiales, Verrucomicrobiota, Akkermansia, and Akkermansia_muciniphila. These gut microbiota were strongly associated with elevated fecal levels of L-tryptophan, 5-hydroxyindoleacetic acid, and N-a-acetylcitrulline, as well as with increased hippocampal concentrations of L-arginine, L-glutamine, N2-succinyl-L-ornithine, N-acetylornithine, indolepyruvate, indoleacetaldehyde, kynurenic acid, 11, 12-EET, 11, 12-DiHETrE and prostaglandin A2, which were almost involved in tryptophan and arginine related metabolism pathways. This study highlights the beneficial effects of FMT strategy in response to demyelination-mediated WMI under chronic cerebral ischemia condition.
Insights
Fecal microbiota transplantation (FMT) may treat chronic cerebral hypoperfusion-induced white matter injury by restoring gut microbiota, improving mitochondrial function, and promoting remyelination. This approach shows promise for central nervous system diseases.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- Fecal microbiota transplantation (FMT) is explored for central nervous system (CNS) diseases.
- The effect of FMT on chronic cerebral hypoperfusion (CCH)-induced white matter injury (WMI) is unclear.
- Investigating FMT's role in myelin integrity, axonal survival, and oligodendrogenesis is crucial.
Purpose of the Study:
- To investigate the potential therapeutic effects and mechanisms of FMT on CCH-induced WMI.
- To evaluate FMT's impact on myelin integrity, axonal survival, and oligodendrogenesis.
- To explore the alterations in gut microbiota and associated metabolites following FMT.
Main Methods:
- Fecal microbiota transplantation (FMT) was administered to a model of chronic cerebral hypoperfusion (CCH).
- Evaluated white matter injury (WMI) markers, including myelin integrity and axonal survival.
- Assessed mitochondrial function (electron transport chain activities, ATP production) and oligodendrogenesis.
- Analyzed gut microbiota composition and fecal/hippocampal metabolite profiles.
Main Results:
- FMT restored mitochondrial electron transport chain (ETC) activities and enhanced ATP production.
- FMT mitigated demyelination and axonal degeneration, partly via oligodendrogenesis-dependent remyelination.
- FMT modulated gut microbiota, increasing specific bacterial groups like Akkermansia muciniphila.
- FMT altered metabolite profiles, including tryptophan and arginine pathways, linked to gut microbiota changes.
Conclusions:
- Fecal microbiota transplantation (FMT) demonstrates beneficial effects against demyelination-related white matter injury (WMI) under chronic cerebral hypoperfusion (CCH).
- FMT improves mitochondrial function and promotes remyelination through oligodendrogenesis.
- The therapeutic effects are associated with significant alterations in gut microbiota composition and related metabolic pathways.
Related Concept Videos
Development of Human Microbiota
Functions of the Gut Microbiota
Gut-Brain Axis

